About Event

Be Part of the Only Event Dedicated to Overcoming Your Daily Challenges Faced In Linker & Conjugation Development

As part of the World ADC Series, the 2nd ADC Linker & Conjugation Summit is the only forum exclusively focused on enhancing your linker and conjugation chemistry. With 100+ attendees ranging from boots-on-the-ground scientists working on improving linker & conjugation chemistries daily, through to more senior directors, this conference is the optimal combination of knowledge sharing and networking.

Leave this summit with the confidence to innovate hydrophilic linkers that help prevent aggregation, enhance stability in linkers & conjugations to ensure tumor targeting and hone site-specific conjugations to guarantee homogenous DAR, all to ultimately ensure ADC stability and widen therapeutic index.

Five reasons you cannot miss out on this event:

https://adc-linker-conjugation.com/wp-content/uploads/sites/867/2024/02/cropped-ADC_Linker___Conjugation_Summit_-_Copy-removebg-preview.png
https://adc-linker-conjugation.com/wp-content/uploads/sites/867/2024/02/cropped-ADC_Linker___Conjugation_Summit_-_Copy-removebg-preview.png
https://adc-linker-conjugation.com/wp-content/uploads/sites/867/2024/02/cropped-ADC_Linker___Conjugation_Summit_-_Copy-removebg-preview.png
https://adc-linker-conjugation.com/wp-content/uploads/sites/867/2024/02/cropped-ADC_Linker___Conjugation_Summit_-_Copy-removebg-preview.png
https://adc-linker-conjugation.com/wp-content/uploads/sites/867/2024/02/cropped-ADC_Linker___Conjugation_Summit_-_Copy-removebg-preview.png

Enhance ADC design by delving into the basics of linker and conjugation chemistries to optimally design linkers that fits your ADCs needs with Exelixis

Explore novel linker & conjugation technologies to develop high DAR ADCs & increase efficacy with Sutro Biopharma

Improve Therapeutic Index of ADCs by optimizing linker stability and ensuring accurate payload release with Iksuda Therapeutics

Analyze new technologies for site-specific conjugations to improve tumor penetration AbTx

Overcome challenges with conjugating novel payloads to ensure stability of conjugation and safe release of payload with BrickBio

Attendees will leave empowered to analyze the right choice of linker and type of conjugation technology to be employed to develop a suite of homogenous ADCs that can provide a real-life benefit to patients.

Who Will You Meet?